Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (15)

2022

  1. Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

    HemaSphere, Vol. 6, Núm. 4

2021

  1. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes

    PloS one, Vol. 16, Núm. 5, pp. e0248886

  2. Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

    PloS one, Vol. 16, Núm. 2, pp. e0247093

  3. Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models

    Frontiers in Oncology, Vol. 11

  4. Safety of FLT3 inhibitors in patients with acute myeloid leukemia

    Expert Review of Hematology, Vol. 14, Núm. 9, pp. 851-865

  5. Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data

    Leukemia, Vol. 35, Núm. 10, pp. 2924-2935

2020

  1. Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study

    Blood, Vol. 135, Núm. 5, pp. 381-386

  2. FLT3 inhibitors in the treatment of acute myeloid leukemia: Current status and future perspectives

    Minerva Medica, Vol. 111, Núm. 5, pp. 427-442

  3. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling

    BMC Cancer, Vol. 20, Núm. 1

2019

  1. The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

    BMC Cancer, Vol. 19, Núm. 1

2014

  1. Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?

    American Journal of Hematology, Vol. 89, Núm. 11, pp. E206-E211

2010

  1. Oligo-secretory myeloma in a patient with ankylosing spondylitis

    Rheumatology International, Vol. 30, Núm. 9, pp. 1227-1229

1999

  1. Correlation and prognostic value of serum soluble ICAM-1, beta-2 microglobulin, and IL-2αR levels in non-Hodgkin's lymphoma

    Leukemia and Lymphoma, Vol. 33, Núm. 5-6, pp. 551-558

1998

  1. Determinación del receptor soluble de la interleucina 2 en el suero de pacientes con linfoma no hodgkiniano

    Medicina Clinica, Vol. 111, Núm. 5, pp. 161-167

1996

  1. Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemia

    Leukemia, Vol. 10, Núm. 10, pp. 1615-1618